Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · IEX Real-Time Price · USD
3.240
+0.160 (5.19%)
Jul 22, 2024, 11:12 AM EDT - Market open
RANI Employees
Rani Therapeutics Holdings had 140 employees as of December 31, 2023. The number of employees decreased by 23 or -14.11% compared to the previous year.
Employees
140
Change (1Y)
-23
Growth (1Y)
-14.11%
Revenue / Employee
n/a
Profits / Employee
-$236,293
Market Cap
155.80M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 140 | -23 | -14.11% |
| Dec 31, 2022 | 163 | 49 | 42.98% |
| Dec 31, 2021 | 114 | 43 | 60.56% |
| Dec 31, 2020 | 71 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| High Tide | 1,550 |
| OptiNose | 132 |
| Kodiak Sciences | 111 |
| Vaxart | 109 |
| Assertio Holdings | 53 |
| Achieve Life Sciences | 22 |
| INmune Bio | 17 |
| Galectin Therapeutics | 14 |
RANI News
- 2 hours ago - Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering - GlobeNewsWire
- 4 weeks ago - Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment - GlobeNewsWire
- 2 months ago - Rani Therapeutics to Participate in May Investor Conferences - GlobeNewsWire
- 2 months ago - Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024 - GlobeNewsWire
- 2 months ago - Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update - GlobeNewsWire
- 4 months ago - Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update - GlobeNewsWire
- 4 months ago - Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 6 months ago - SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) - PRNewsWire